Objective Measurement of the Mechanical Pain Threshold With an Algometer for Predicting Intraoperative Opioid Consumption in Patients Who Will be Operate by Thoracotomy and Sternotomy in Cardiac Surgery

April 4, 2026 updated by: ASSERAF NATHAN, Université Libre de Bruxelles

The Usefulness of Preoperative Measurement of the Mechanical Pain Threshold for Predicting Intraoperative Opioid Consumption

The study aims to test the relationship between the preoperative pain threshold and the intraoperative need for opioids.

The objective of the study is to try to predict a patient's analgesic needs based on their objectively determined preoperative pain threshold.

The investigators will include patients scheduled for elective cardiovascular surgery.

The investigators will investigate the correlation between the preoperative pain threshold and intraoperative/postoperative opioid consumption in a highly standardized anesthesia setting.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Anderlecht
      • Brussels, Anderlecht, Belgium, 1070
        • Recruiting
        • Erasme Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • IONUT TABOLCEA, Doctor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ASA 3 patients with scheduled cardiac surgery by thoracotomy or sternotomy

Exclusion Criteria:

  • Patient refusal,
  • A body mass index (BMI) > 30 kg/m²,
  • Allergies to any medication used in typical cardiac anesthesia,
  • Chronic pain or regular use of analgesics,
  • Severe ventricular dysfunction, pulmonary hypertension, poorly controlled arhythmia,
  • Non-elective surgery.
  • Patients enrolled in another study protocol within the previous 3 months,
  • Pregnant or breastfeeding patients,
  • Patients with severe renal or hepatic impairment.
  • Patients for whom the study will be stopped in the event of blood loss greater than or equal to one liter, or for any other severe perioperative surgical complication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: pain threshold arm
In this arm, patients get a measure of their minimal pain threshold in the preoperative time, that is the only intervention they get in addition of the classic care support
The measure of the minimal pain threshold is taken the day before the cardiac surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between the pressure pain threshold and the consumption of opioid during and after the surgery
Time Frame: From enrollment to the end of opioid administration during hospital stay, up to 6 days after the enrollment
After the measure of the minimal pain threshold the day before the surgery, the investigators look at the quantity of Remifentanil which has been given to the patient during the surgery. Then they will look for a correlation
From enrollment to the end of opioid administration during hospital stay, up to 6 days after the enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between the pain threshold and the consumption of morphine during the post-operative time
Time Frame: From enrollment to the end of opioid administration during hospital stay, up to 6 days after the enrollment
After the measure of the minimal pain threshold the day before the surgery, the investigators look at the quantity of morphine which has been administrated by a PCA (Intravenous Patient-Controlled Analgesia (IV-PCA) with morphine) to the patient during the post-operative time. Then they are looking for a correlation.
From enrollment to the end of opioid administration during hospital stay, up to 6 days after the enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: IONUT TABOLCEA, Doctor, Erasme University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 24, 2026

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

December 15, 2026

Study Registration Dates

First Submitted

March 27, 2026

First Submitted That Met QC Criteria

April 4, 2026

First Posted (Actual)

April 7, 2026

Study Record Updates

Last Update Posted (Actual)

April 7, 2026

Last Update Submitted That Met QC Criteria

April 4, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HUB2025080

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

all IPD collected throughout the trial

IPD Sharing Time Frame

Beginning 1 month after publication with no end date

IPD Sharing Access Criteria

reserchers working in the same area of research

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Surgery Subjects

Clinical Trials on Measure of the minimal pain threshold with an algometer

Subscribe